CSS LLC’s iShares Biotechnology ETF IBB Stock Holding History

CSS LLC’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-25,000	Closed	-$2.92M	–	1019
2022 Q3	$2.92M	Sell	25,000 -15,000	-38%	-$1.86M	0.14%	168
2022 Q2	$4.71M	Buy	40,000 +15,000	+60%	+$1.78M	0.19%	115
2022 Q1	$3.26M	Buy	+25,000	New	+$3.26M	0.12%	169
2021 Q4	–	Sell	-10,000	Closed	-$1.62M	–	1276
2021 Q3	$1.62M	Buy	+10,000	New	+$1.68M	0.07%	291

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CANY

Caxton Associates (New York) New York $3.18B AUM 54.49% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

CSS LLC's IBB Position: Q1 2022 in Review

CSS LLC sold out of iShares Biotechnology ETF (IBB) in Q1 2022, closing a stake of 901 shares — an estimated $117K sold.

CSS LLC first reported a position in IBB in Q3 2021 and held it in 2 quarters. The position peaked at $1.37M in Q3 2021. 897 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

CSS LLC reported no remaining iShares Biotechnology ETF position as of Q1 2022 after selling out during the quarter.
CSS LLC sold 901 iShares Biotechnology ETF shares in Q1 2022, an estimated $117K.
CSS LLC first reported a position in iShares Biotechnology ETF in Q3 2021 and held it in 2 quarters.
CSS LLC's iShares Biotechnology ETF position peaked at $1.37M in Q3 2021.
897 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on CSS LLC's 13F filing for Q1 2022, filed 16 May 2022.